Celgene 1Q net income slips on marketing costs
SUMMIT, N.J. (AP) — Celgene's net income fell 4 percent in the first quarter as marketing costs increased following the marketing approval of two drugs. The Food and Drug Administration broadened the approval of Celgene's drug Abraxane during the …
See all stories on this topic »
Personal Branding Guide | Marketing Yourself To Employers
Do you know what your personal brand is? Are you aware of the importance of having a strong, unique and diverse personal brand? Here is how to define one.WISH
See all stories on this topic »
Business Marketing Association Expands Global Presence
The latest chapter is part of the organization's objective to provide business-to-business (B2B) marketing professionals around the world with the resources and support to enhance their practices and expand their careers. Beginning immediately, BMA …
See all stories on this topic »
